Securities Code: 300142 Securities Abbreviation: Wonbio Announcement Number: 2026-060
Yunnan Wonbio Biotech Co., Ltd.
Announcement on Public Solicitation of Voting Rights by China Securities Investor Protection Center Co., Ltd.
China Securities Investor Protection Center Co., Ltd. guarantees that the information provided to this company is true, accurate, and complete, and contains no false records, misleading statements, or material omissions.
This company and the board of directors guarantee that the content of this announcement is consistent with the information provided by the information disclosure obligor.
Special Statement
-
This solicitation of voting rights is conducted through public solicitation in accordance with the law. The solicitor, China Securities Investor Protection Center Co., Ltd. (hereinafter referred to as CSIPC), is a public interest investor protection institution directly managed by the China Securities Regulatory Commission, and meets the solicitation conditions stipulated in Article 90 of the "Securities Law," Article 32 of the "Rules for Shareholders' Meetings of Listed Companies," and Article 3 of the "Interim Measures for Public Solicitation of Listed Company Shareholder Rights."
-
The solicitor undertakes not to transfer its shares from the date of solicitation until the announcement of the resolution of the shareholders' meeting to deliberate the solicited proposal.
I. Basic Information of the Solicitor
(I) Basic Information and Shareholding of the Solicitor
Full Name of Solicitor: China Securities Investor Protection Center Co., Ltd.
Unified Social Credit Code: 91310109324690714C
Address: No. 15, Lane 110, Guyuan Road, Hongkou District, Shanghai
Legal Representative: Lu Wenda
-1-
Type of Enterprise: Other Limited Liability Company
Date of Establishment: December 5, 2014
Term of Operation: Long-term
Business Scope: Publicity and education for investors; exercising rights as a shareholder or security holder for public interest holdings of securities and other products; providing dispute resolution services entrusted by investors; supporting public interest litigation for investors and related work; construction, management, and operation of the China Investor Website; investigation and monitoring of investor intentions and demands, conducting strategic research and planning; reflecting demands to government agencies and regulatory departments on behalf of investors; other businesses entrusted by the China Securities Regulatory Commission.
Number of Shares Held: 100 shares
Shareholding Ratio: 0.0000063%
Nature of Shareholding: Negotiable shares with no trading restrictions
(II) Relationship of the Solicitor's Interests
There is no relationship between the solicitor and the directors, senior management, shareholders holding more than 5% of shares, actual controllers, or their related parties of the listed company.
II. Solicitor's Voting Opinion and Reasons for Voting on the Matters for Voting
(I) Solicitor's Voting Opinion on the Matters for Voting
Ms. Wang Yingdian is an independent director candidate nominated by the solicitor. The solicitor is soliciting voting rights from all shareholders solely for the "Proposal on the Appointment of Independent Directors for the Sixth Board of Directors." Regarding Proposal 1.00, "Proposal on the Appointment of Independent Directors for the Sixth Board of Directors," the voting opinion is "Agree." For details of the voting opinion, please refer to the table below (Note: The solicitor does not accept entrustments with voting opinions inconsistent with the solicitor's voting opinion).
-2-
Proposal Code
Non-cumulative Voting Proposal Name
Agree
Disagree
Abstain
1.00
"Proposal on the Appointment of Independent Directors for the Sixth Board of Directors"
√
Given that voting rights are being solicited only for some proposals to be deliberated at the third extraordinary general meeting of shareholders in 2026, the solicitor specifically reminds the solicited parties that, in addition to the proposals for which CSIPC is publicly soliciting voting rights, the solicited parties should indicate their voting opinions on other proposals in the power of attorney and entrust CSIPC to vote on their behalf.
(II) Solicitor's Reasons for Voting
Mr. Wang Yingdian has a background in biological products and relevant experience as an independent director. He has no record of major dishonesty or other negative records, possesses independence, and meets the requirements